Century Therapeutics Insider Sale: Carr Douglas’ Tax‑Triggered Trade Signals Long‑Term Confidence
Insider sale: Carr Douglas sells 323 shares of Century Therapeutics for $1.82 each – a tax‑triggered move that leaves his stake stable amid a volatile, high‑risk stem‑cell biotech landscape and upcoming regulatory milestones.
4 minutes to read